Headquartered in Leamington, ON Fiscal year ends May NASDAQ: TLRY tilray.com
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company operating at the intersection of cannabis, beverage, hospitality, wellness, and pharmaceutical distribution. The company operates across Canada, the United States, Europe, Australia, and Latin America, supporting over 40 brands in over 20 countries. In cannabis, Tilray has more than 6 million square feet of cultivation capacity across Canada, Portugal, and Germany, with one of the largest EU-GMP certified production footprints globally. In beverages, the company is the #4 craft brewer in the U.S. and #1 in the U.K., and has expanded through the acquisition of BrewDog. The Distribution segment operates a pharmaceutical distribution business primarily in Europe. The Wellness segment encompasses hemp-based food products. Tilray trades on both Nasdaq and the Toronto Stock Exchange under the ticker TLRY. Updated
BrewDog lifted beverage revenue 82% to $101.5 million, yet both EPS and revenue missed expectations. Management reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million, leaning on second-half seasonality and the Carlsberg US launch in January.
Tilray reports before the open with three straight EPS misses behind it, the latest a $0.43 loss against a $0.02 estimate. Consensus looks for $0.04 and $267.76 million in revenue, and with a $549.7 million market cap, a fourth miss leaves rescheduling hope doing all the work.
A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company’s following moved the wrong way. Tilray Brands shares are at $3.56, down…
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
Tilray Brands reports Q4 FY2026 earnings tonight with shares down sharply on the year, a beverage segment under pressure, and CEO Irwin Simon's EBITDA guidance on the line after a Q3 EPS…
Thomas Richmond Quantum computing stocks are posting four-digit revenue growth rates, and the hype feels impossible to argue with until you remember that 3D Systems, Tilray, and Cisco all looked just as unstoppable right…
Cannabis investors have watched rescheduling euphoria ignite and incinerate capital at least four times since 2018, and a fresh DEA hearing is now on the calendar. The question is whether this cycle…
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to Schedule…
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation…
Tilray Brands (NASDAQ:TLRY) shares declined 4% in Wednesday morning trading, falling to around $6.20 after opening at $6.47. The drop came despite the company posting what it called a record Q3 result,…
David Moadel Live Updates Insiders are Buying One of the Market’s Worst Performing Stocks1:24pm ETIt’s always a good idea to keep an eye on insider buying. After all, it’s the insiders who know their…
The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like…
Live Updates Is PayPal Stock No Longer a Buy?11:40am ETBaird analyst Colin Sebastian downgraded PayPal (Nasdaq: PYPL | PYPL Price Prediction) stock to neutral with a $66 price target this morning. “We were…
Pre-Market Stock Futures: Futures are trading lower after a big rate-cut rally on Wednesday was sideswiped by Oracle’s disappointing earnings after the bell yesterday. The Federal Reserve’s 25-basis-point rate cut, as expected,…
Live Updates Guidance Update7:45am ETTilray reiterated its FY2026 Adjusted EBITDA outlook of $62M–$72M, signaling confidence in execution despite mixed segment margins. The company noted continued focus on operational discipline and expects margin…
Joel South It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector, envisioning a booming…
From Hype to Hiccups in the Cannabis Craze Once hailed as the “next big thing,” cannabis stocks in 2018-2019 were the artificial intelligence stock darlings of their day, riding a wave of…
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company operating at the intersection of cannabis, beverage, hospitality, wellness, and pharmaceutical distribution.
The Wall Street consensus 12-month price target for TLRY is $5.89.
